• p21-ELP1-Bac Delivery Suppresses Glioblastoma Growth

  2026-08-25

  The reference study shows that an elastin-like polypeptide and cell-penetrating peptide can deliver a p21-derived inhibitor into glioblastoma cells and suppress proliferation across biologically distinct models. Its low apoptotic response supports a predominantly cytostatic interpretation, while differences between U87, GBM43, and GBM6 highlight the importance of lineage and drug-tolerance context in evaluating intracellular peptide therapies.

• Salvianolic acid B: Reliable Cell Assay Design

  2026-08-25

  Learn how Salvianolic acid B, SKU N1806, can support more interpretable viability, proliferation, and cytotoxicity experiments in pulmonary fibrosis research. This scenario-driven guide covers assay interference, solvent compatibility, dose optimization, data interpretation, and practical product selection using documented quality and solubility specifications.

• Trelagliptin succinate in Diabetes Research

  2026-08-24

  Trelagliptin succinate enables a practical bridge from DPP-4 enzyme inhibition to cellular, metabolic, and diabetes-associated cognitive assays. This workflow shows how to select concentrations, connect pathway readouts, and troubleshoot exposure, controls, and interpretation using SYR-472 succinate.

• HBTU: Precision in Peptide Probe Translation

  2026-08-23

  HBTU links controlled carboxylic acid activation with the reproducible synthesis of peptide-based activity probes. This thought-leadership perspective examines how 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate can support immunoproteasome research while distinguishing chemical workflow evidence from biological and translational validation.

• Propranolol: From β-Blockade to Translational Insight

  2026-08-22

  Propranolol is more than a cardiovascular tool: its peripheral β1/β2 blockade and putative central noradrenergic–GABAergic effects create a tractable platform for connecting receptor pharmacology with tremor, emotional memory, and metabolic phenotypes. TMS-informed study design can help translational researchers distinguish mechanism from association.

• Catalpol in Cardio-Cerebrovascular Disease: Review

  2026-08-21

  This comprehensive review organizes evidence that catalpol may protect the cardiovascular and cerebrovascular systems through coordinated antioxidant, anti-inflammatory, mitochondrial, and anti-apoptotic mechanisms. Its main practical contribution is a disease-oriented framework linking signaling pathways with atherosclerosis, myocardial injury, cardiac remodeling, diabetic complications, and thrombosis while emphasizing the limited clinical evidence.

• Leptin (116-130), amide, mouse: A Translational Lens

  2026-08-20

  A mechanistic and strategic guide to using Leptin (116-130), amide, mouse as a defined perturbation tool for energy homeostasis regulation, obesity and diabetes research, and emerging immunometabolic questions.

• YM-155 hydrochloride: Assay Workflows

  2026-08-20

  Use YM-155 hydrochloride as a selective survivin inhibitor while separating growth arrest from genuine cell killing. This practical workflow combines dose-response design, orthogonal viability measurements, and troubleshooting for apoptosis inhibitor research across cancer cell models.

• Propranolol in Avian Hair-Cell Research

  2026-08-19

  Explore how Propranolol can be evaluated as a mechanistic perturbation alongside a multimodal avian hair-cell injury assay. This article connects β-adrenergic pharmacology with spatial mRNA, protein, and S-phase measurements while clearly separating established protocol evidence from future research hypotheses.

• Scalable EPSC-iMSC EV Production: Study Insights

  2026-08-19

  Gong et al. developed a bioreactor-based platform that combines extended pluripotent stem cell-derived mesenchymal stromal cells with automated extracellular vesicle production. The resulting iMSC-EVs showed primary MSC-EV-like characteristics and therapeutic activity in a mouse pulmonary fibrosis model, providing a practical framework for more standardized EV manufacturing.

• 3-Methyladenine in Autophagy Workflows

  2026-08-18

  3-Methyladenine provides a practical way to perturb class III PI3K-dependent autophagy while exposing timing-dependent effects on broader PI3K signaling. This guide translates that profile into workflows for OGD/R injury, nutrient-stress cancer research, and cell migration inhibition, with controls and troubleshooting built in.

• TMEM16F, Ferroptosis, and Tumor Immune Rejection

  2026-08-18

  Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as a late-stage defense against ferroptotic membrane collapse. Loss or suppression of this process increases lytic damage and danger-signal release, while combining lipid-scrambling inhibition with PD-1 blockade produces stronger tumor rejection in preclinical models.

• E-4031 Workflows for hERG Cardiac Studies

  2026-08-17

  Build reproducible cardiac electrophysiology assays with E-4031, a potent hERG potassium channel blocker for concentration–response, QT interval prolongation, and proarrhythmic substrate modeling. The workflow combines practical dosing, 2D and 3D readouts, and troubleshooting controls while keeping preclinical interpretation separate from clinical claims.

• Gamithromycin: From MIC to Lung PK/PD

  2026-08-17

  Gamithromycin research is most informative when MIC data are connected to unbound exposure and pulmonary distribution. This evidence-led guide translates the ML-1709460 PK/PD model into practical assay, interpretation, and veterinary research decisions.

• Ginsenoside Rg1 Restores the Gut–Immune–Brain Axis

  2026-08-16

  A 2025 Journal of Ethnopharmacology study identifies regulatory T cells as a necessary component of Ginsenoside Rg1-mediated protection against prolonged isoflurane-induced neuroimmune disruption in mice. By integrating behavioral, synaptic, inflammatory, intestinal-barrier, and Treg measurements, the work links gut–immune–brain axis restoration with improved postoperative-relevant neurological outcomes.

453 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page